Report Detail

Pharma & Healthcare Global Human Vaccines Market Insights, Forecast to 2025

  • RnM2359191
  • |
  • 22 May, 2019
  • |
  • Global
  • |
  • 128 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as a threat, destroy it, and keep a record of it so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters. Vaccines can be prophylactic (example: to prevent or ameliorate the effects of a future infection by any natural or "wild" pathogen), or therapeutic (e.g., vaccines against cancer are being investigated).
The global Human Vaccines market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Human Vaccines market based on company, product type, end user and key regions.

This report studies the global market size of Human Vaccines in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Human Vaccines in these regions.
This research report categorizes the global Human Vaccines market by top players/brands, region, type and end user. This report also studies the global Human Vaccines market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
CNBG
Changsheng Life
Zhifei
ChengDa Bio
Kangtai
SINOVAC BIOTECH
Hissen
Walvax Biotechnology
GSK
SANOFI
Rong An
NuoCheng Bio
Hualan Bio
Tiantan biological
Changchun Baike
Adimmune
Zhongyianke Biotech

Market size by Product
Varicella
Influenza
Polio
Hepatitis A
Rabies
BCG
Hepatitis B
Other
Market size by End User
Adults
Children

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Human Vaccines market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Human Vaccines market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Human Vaccines companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Human Vaccines submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Human Vaccines are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Human Vaccines market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


Table of Contents

    1 Study Coverage

    • 1.1 Human Vaccines Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Human Vaccines Market Size Growth Rate by Product
      • 1.4.2 Varicella
      • 1.4.3 Influenza
      • 1.4.4 Polio
      • 1.4.5 Hepatitis A
      • 1.4.6 Rabies
      • 1.4.7 BCG
      • 1.4.8 Hepatitis B
      • 1.4.9 Other
    • 1.5 Market by End User
      • 1.5.1 Global Human Vaccines Market Size Growth Rate by End User
      • 1.5.2 Adults
      • 1.5.3 Children
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Human Vaccines Market Size
      • 2.1.1 Global Human Vaccines Revenue 2014-2025
      • 2.1.2 Global Human Vaccines Sales 2014-2025
    • 2.2 Human Vaccines Growth Rate by Regions
      • 2.2.1 Global Human Vaccines Sales by Regions
      • 2.2.2 Global Human Vaccines Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Human Vaccines Sales by Manufacturers
      • 3.1.1 Human Vaccines Sales by Manufacturers
      • 3.1.2 Human Vaccines Sales Market Share by Manufacturers
      • 3.1.3 Global Human Vaccines Market Concentration Ratio (CR5 and HHI)
    • 3.2 Human Vaccines Revenue by Manufacturers
      • 3.2.1 Human Vaccines Revenue by Manufacturers (2014-2019)
      • 3.2.2 Human Vaccines Revenue Share by Manufacturers (2014-2019)
    • 3.3 Human Vaccines Price by Manufacturers
    • 3.4 Human Vaccines Manufacturing Base Distribution, Product Types
      • 3.4.1 Human Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Human Vaccines Product Type
      • 3.4.3 Date of International Manufacturers Enter into Human Vaccines Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Human Vaccines Sales by Product
    • 4.2 Global Human Vaccines Revenue by Product
    • 4.3 Human Vaccines Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Human Vaccines Breakdown Data by End User

    6 North America

    • 6.1 North America Human Vaccines by Countries
      • 6.1.1 North America Human Vaccines Sales by Countries
      • 6.1.2 North America Human Vaccines Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Human Vaccines by Product
    • 6.3 North America Human Vaccines by End User

    7 Europe

    • 7.1 Europe Human Vaccines by Countries
      • 7.1.1 Europe Human Vaccines Sales by Countries
      • 7.1.2 Europe Human Vaccines Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Human Vaccines by Product
    • 7.3 Europe Human Vaccines by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Human Vaccines by Countries
      • 8.1.1 Asia Pacific Human Vaccines Sales by Countries
      • 8.1.2 Asia Pacific Human Vaccines Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Human Vaccines by Product
    • 8.3 Asia Pacific Human Vaccines by End User

    9 Central & South America

    • 9.1 Central & South America Human Vaccines by Countries
      • 9.1.1 Central & South America Human Vaccines Sales by Countries
      • 9.1.2 Central & South America Human Vaccines Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Human Vaccines by Product
    • 9.3 Central & South America Human Vaccines by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Human Vaccines by Countries
      • 10.1.1 Middle East and Africa Human Vaccines Sales by Countries
      • 10.1.2 Middle East and Africa Human Vaccines Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Human Vaccines by Product
    • 10.3 Middle East and Africa Human Vaccines by End User

    11 Company Profiles

    • 11.1 CNBG
      • 11.1.1 CNBG Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 CNBG Human Vaccines Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 CNBG Human Vaccines Products Offered
      • 11.1.5 CNBG Recent Development
    • 11.2 Changsheng Life
      • 11.2.1 Changsheng Life Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Changsheng Life Human Vaccines Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Changsheng Life Human Vaccines Products Offered
      • 11.2.5 Changsheng Life Recent Development
    • 11.3 Zhifei
      • 11.3.1 Zhifei Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Zhifei Human Vaccines Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Zhifei Human Vaccines Products Offered
      • 11.3.5 Zhifei Recent Development
    • 11.4 ChengDa Bio
      • 11.4.1 ChengDa Bio Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 ChengDa Bio Human Vaccines Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 ChengDa Bio Human Vaccines Products Offered
      • 11.4.5 ChengDa Bio Recent Development
    • 11.5 Kangtai
      • 11.5.1 Kangtai Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Kangtai Human Vaccines Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Kangtai Human Vaccines Products Offered
      • 11.5.5 Kangtai Recent Development
    • 11.6 SINOVAC BIOTECH
      • 11.6.1 SINOVAC BIOTECH Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 SINOVAC BIOTECH Human Vaccines Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 SINOVAC BIOTECH Human Vaccines Products Offered
      • 11.6.5 SINOVAC BIOTECH Recent Development
    • 11.7 Hissen
      • 11.7.1 Hissen Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Hissen Human Vaccines Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Hissen Human Vaccines Products Offered
      • 11.7.5 Hissen Recent Development
    • 11.8 Walvax Biotechnology
      • 11.8.1 Walvax Biotechnology Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Walvax Biotechnology Human Vaccines Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Walvax Biotechnology Human Vaccines Products Offered
      • 11.8.5 Walvax Biotechnology Recent Development
    • 11.9 GSK
      • 11.9.1 GSK Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 GSK Human Vaccines Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 GSK Human Vaccines Products Offered
      • 11.9.5 GSK Recent Development
    • 11.10 SANOFI
      • 11.10.1 SANOFI Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 SANOFI Human Vaccines Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 SANOFI Human Vaccines Products Offered
      • 11.10.5 SANOFI Recent Development
    • 11.11 Rong An
    • 11.12 NuoCheng Bio
    • 11.13 Hualan Bio
    • 11.14 Tiantan biological
    • 11.15 Changchun Baike
    • 11.16 Adimmune
    • 11.17 Zhongyianke Biotech

    12 Future Forecast

    • 12.1 Human Vaccines Market Forecast by Regions
      • 12.1.1 Global Human Vaccines Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Human Vaccines Revenue Forecast by Regions 2019-2025
    • 12.2 Human Vaccines Market Forecast by Product
      • 12.2.1 Global Human Vaccines Sales Forecast by Product 2019-2025
      • 12.2.2 Global Human Vaccines Revenue Forecast by Product 2019-2025
    • 12.3 Human Vaccines Market Forecast by End User
    • 12.4 North America Human Vaccines Forecast
    • 12.5 Europe Human Vaccines Forecast
    • 12.6 Asia Pacific Human Vaccines Forecast
    • 12.7 Central & South America Human Vaccines Forecast
    • 12.8 Middle East and Africa Human Vaccines Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Human Vaccines Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Summary:
      Get latest Market Research Reports on Human Vaccines . Industry analysis & Market Report on Human Vaccines is a syndicated market report, published as Global Human Vaccines Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Human Vaccines market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      3,088.80
      4,633.20
      6,177.60
      3,611.40
      5,417.10
      7,222.80
      590,265.00
      885,397.50
      1,180,530.00
      325,260.00
      487,890.00
      650,520.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report